-
1
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
-
Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909.
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
2
-
-
0023922084
-
Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer-report of a Canadian multicenter randomized trial
-
Rapp E, Pater JL, Willan A, Cormier Y, Murray N, Evans WK, Hodson DI, Clark DA, Feld R, Arnold AM, Ayoub JI, Wilson KS, Latreille J, Wierzbicki RF, Hill DP: Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer-report of a Canadian multicenter randomized trial. J Clin Oncol 1988;6:633-641.
-
(1988)
J Clin Oncol
, vol.6
, pp. 633-641
-
-
Rapp, E.1
Pater, J.L.2
Willan, A.3
Cormier, Y.4
Murray, N.5
Evans, W.K.6
Hodson, D.I.7
Clark, D.A.8
Feld, R.9
Arnold, A.M.10
Ayoub, J.I.11
Wilson, K.S.12
Latreille, J.13
Wierzbicki, R.F.14
Hill, D.P.15
-
3
-
-
0022340594
-
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
-
Hsiang YH, Hertzberg R, Hecht S, Liu LF: Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Biol Chem 1985;260:14873-14878.
-
(1985)
Biol Chem
, vol.260
, pp. 14873-14878
-
-
Hsiang, Y.H.1
Hertzberg, R.2
Hecht, S.3
Liu, L.F.4
-
4
-
-
0023433855
-
Supercoiling of the DNA template during transcription
-
Liu LF, Wang JC: Supercoiling of the DNA template during transcription. Proc Natl Acad Sci USA 1987;84:7024-7027.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 7024-7027
-
-
Liu, L.F.1
Wang, J.C.2
-
5
-
-
0026680292
-
CPT-11: A new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer
-
Masuda N, Fukuoka M, Kusunoki Y, Matsui K, Takifuji N, Kudoh S, Negoro S, Nishioka M, Nakagawa K, Takada M: CPT-11: A new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. J Clin Oncol 1992;10:1225-1229.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1225-1229
-
-
Masuda, N.1
Fukuoka, M.2
Kusunoki, Y.3
Matsui, K.4
Takifuji, N.5
Kudoh, S.6
Negoro, S.7
Nishioka, M.8
Nakagawa, K.9
Takada, M.10
-
6
-
-
0025129894
-
An early phase II study of CPT-11: A new derivative of camptothecin, for the treatment of leukemia and lymphoma
-
Ohno R, Okada K, Masaoka T, Kuramoto A, Arima T, Yoshida Y, Ariyoshi H, Ichimura M, Sakai Y, Ogura M, Ito Y, Morishima Y, Yokomaku S, Ota K: An early phase II study of CPT-11: A new derivative of camptothecin, for the treatment of leukemia and lymphoma. J Clin Oncol 1990;8:1907-1912.
-
(1990)
J Clin Oncol
, vol.8
, pp. 1907-1912
-
-
Ohno, R.1
Okada, K.2
Masaoka, T.3
Kuramoto, A.4
Arima, T.5
Yoshida, Y.6
Ariyoshi, H.7
Ichimura, M.8
Sakai, Y.9
Ogura, M.10
Ito, Y.11
Morishima, Y.12
Yokomaku, S.13
Ota, K.14
-
7
-
-
0038140203
-
Phase II study of CPT-11, new camptothecin derivative, in the patients with metastatic colorectal cancer
-
Shimada Y, Yoshino M, Wakui A, Nakao I, Futatsuki K, Sakata Y, Kambe M, Taguchi T: Phase II study of CPT-11, new camptothecin derivative, in the patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol 1991;10:135.
-
(1991)
Proc Am Soc Clin Oncol
, vol.10
, pp. 135
-
-
Shimada, Y.1
Yoshino, M.2
Wakui, A.3
Nakao, I.4
Futatsuki, K.5
Sakata, Y.6
Kambe, M.7
Taguchi, T.8
-
8
-
-
0038816859
-
An early phase II study of CPT-11 for gynecologic cancers
-
Takeuchi S, Takamizawa H, Takeda Y, Ohkawa T, Tamaya T, Noda K, Sugawa T, Sekibe K, Yakushiji M, Taguchi T: An early phase II study of CPT-11 for gynecologic cancers (in Japanese). Gan To Kagaku Ryoho 1991;18:578-584.
-
(1991)
Gan To Kagaku Ryoho
, vol.18
, pp. 578-584
-
-
Takeuchi, S.1
Takamizawa, H.2
Takeda, Y.3
Ohkawa, T.4
Tamaya, T.5
Noda, K.6
Sugawa, T.7
Sekibe, K.8
Yakushiji, M.9
Taguchi, T.10
-
9
-
-
0026531753
-
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer
-
Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S, Masuda N, Nakajima S, Taguchi T: A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. J Clin Oncol 1992;10:16-20.
-
(1992)
J Clin Oncol
, vol.10
, pp. 16-20
-
-
Fukuoka, M.1
Niitani, H.2
Suzuki, A.3
Motomiya, M.4
Hasegawa, K.5
Nishiwaki, Y.6
Kuriyama, T.7
Ariyoshi, Y.8
Negoro, S.9
Masuda, N.10
Nakajima, S.11
Taguchi, T.12
-
10
-
-
7144256258
-
A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer
-
Masuda N, Fukuoka M, Fujita A, Tuschiya S, Nagao K, Negoro S, Nishikawa H, Katakami N, Nakagawa K, Niitani H: A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. Br J Cancer 1998;78:251-256.
-
(1998)
Br J Cancer
, vol.78
, pp. 251-256
-
-
Masuda, N.1
Fukuoka, M.2
Fujita, A.3
Tuschiya, S.4
Nagao, K.5
Negoro, S.6
Nishikawa, H.7
Katakami, N.8
Nakagawa, K.9
Niitani, H.10
-
11
-
-
0030020182
-
Promising new agents in the treatment of non-small cell lung cancer
-
Edelmen MJ, Gandara DR: Promising new agents in the treatment of non-small cell lung cancer. Cancer Chemther Phamacol 1996;37:385-393.
-
(1996)
Cancer Chemther Phamacol
, vol.37
, pp. 385-393
-
-
Edelmen, M.J.1
Gandara, D.R.2
-
12
-
-
0030007671
-
Recent advances in the treatment of non-small cell lung cancer
-
Goss GD, Dahrouge S, Lochrin CA: Recent advances in the treatment of non-small cell lung cancer. Anti-Cancer Drugs 1996;7:363-385.
-
(1996)
Anti-Cancer Drugs
, vol.7
, pp. 363-385
-
-
Goss, G.D.1
Dahrouge, S.2
Lochrin, C.A.3
-
13
-
-
0342600736
-
Ifosfamide in the treatment of bronchial carcinoma
-
Drings P: Ifosfamide in the treatment of bronchial carcinoma. Contr Oncol 1987;26:294-318.
-
(1987)
Contr Oncol
, vol.26
, pp. 294-318
-
-
Drings, P.1
-
14
-
-
0024502276
-
European experience with ifosfamide in non-small-cell lung cancer
-
Drings P: European experience with ifosfamide in non-small-cell lung cancer. Semin Oncol 1989;16(suppl 3):22-30.
-
(1989)
Semin Oncol
, vol.16
, Issue.SUPPL. 3
, pp. 22-30
-
-
Drings, P.1
-
15
-
-
0025892245
-
Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 Leukemia
-
Furuta T, Yokokura T: Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 Leukemia (in Japanese). Gan To Kagaku Ryoho 1991;18:393-402.
-
(1991)
Gan To Kagaku Ryoho
, vol.18
, pp. 393-402
-
-
Furuta, T.1
Yokokura, T.2
-
16
-
-
0026587170
-
Effects of CPT-11 in combination with other anti-cancer agents in culture
-
Kano Y, Suzuki K, Akutsu M, Suda K, Inoue Y, Yoshida M, Sakamoto S, Miura Y: Effects of CPT-11 in combination with other anti-cancer agents in culture. Int J Cancer 1992;50:604-610.
-
(1992)
Int J Cancer
, vol.50
, pp. 604-610
-
-
Kano, Y.1
Suzuki, K.2
Akutsu, M.3
Suda, K.4
Inoue, Y.5
Yoshida, M.6
Sakamoto, S.7
Miura, Y.8
-
17
-
-
0023864510
-
Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo
-
Tsuruo T, Matsuzaki T, Matsushita M, Saito H, Yokokura T: Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo. Cancer Chemother Phamacol 1988;21:71-74.
-
(1988)
Cancer Chemother Phamacol
, vol.21
, pp. 71-74
-
-
Tsuruo, T.1
Matsuzaki, T.2
Matsushita, M.3
Saito, H.4
Yokokura, T.5
-
18
-
-
0032875061
-
Phase I study of a combination of Irinotecan and Ifosfamide in advanced primary lung cancer
-
Ichiki M, Rikimaru T, Okubo Y, Gohara R, Mitui T, Kawayama T, Kinoshita M, Oizumi K: Phase I study of a combination of Irinotecan and Ifosfamide in advanced primary lung cancer. Kurume Med J 1999;46:111-115.
-
(1999)
Kurume Med J
, vol.46
, pp. 111-115
-
-
Ichiki, M.1
Rikimaru, T.2
Okubo, Y.3
Gohara, R.4
Mitui, T.5
Kawayama, T.6
Kinoshita, M.7
Oizumi, K.8
-
20
-
-
0020396015
-
Toxicity and response criteria of the Eastern Cooperative Oncology Group
-
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
-
(1982)
Am J Clin Oncol
, vol.5
, pp. 649-655
-
-
Oken, M.M.1
Creech, R.H.2
Tormey, D.C.3
Horton, J.4
Davis, T.E.5
McFadden, E.T.6
Carbone, P.P.7
-
21
-
-
0033988085
-
Activity of docetaxel in platinum-treated non-small-cell lung cancer: Results of a phase II multicenter trial
-
Gandara DR, Vokes E, Green M, Bonomi P, Devore R, Comis R, Carbone D, Karp D, Belani C: Activity of docetaxel in platinum-treated non-small-cell lung cancer: Results of a phase II multicenter trial. J Clin Oncol 2000;18:131-135.
-
(2000)
J Clin Oncol
, vol.18
, pp. 131-135
-
-
Gandara, D.R.1
Vokes, E.2
Green, M.3
Bonomi, P.4
Devore, R.5
Comis, R.6
Carbone, D.7
Karp, D.8
Belani, C.9
-
22
-
-
0003228146
-
2 vs vinorelbine/ifosfamide for non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy (PBC)
-
2 vs vinorelbine/ifosfamide for non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy (PBC). Proc Am Soc Clin Oncol 1999;18:460a.
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Fossella, F.V.1
DeVore, R.2
Kerr, R.3
Crawford, R.4
Natale, R.5
Dunphy, F.6
Kalman, L.7
Gandara, D.8
Gamza, F.9
Hammershaimb, L.10
Kim, Y.11
Crist, W.12
-
23
-
-
0000828452
-
A EORTC randomized phase III trial of three chemotherapy regimens in advanced non-small cell lung cancer (NSCLC)
-
Van Meerbeeck JP, Smit EF, Lianes P, Schramel F, Lenz M, Debruyne C, Giaccone G: A EORTC randomized phase III trial of three chemotherapy regimens in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2001;20:308a.
-
(2001)
Proc Am Soc Clin Oncol
, vol.20
-
-
Van Meerbeeck, J.P.1
Smit, E.F.2
Lianes, P.3
Schramel, F.4
Lenz, M.5
Debruyne, C.6
Giaccone, G.7
-
24
-
-
0035849269
-
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: A randomised multicentre trial
-
Georgoulias V, Papadakis E, Alexopoulos A, Taiafaki X, Rapti A, Veslemes M, Palamidas P, Vlachonikolis I: Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. Lancet 2001;357:1478-1484.
-
(2001)
Lancet
, vol.357
, pp. 1478-1484
-
-
Georgoulias, V.1
Papadakis, E.2
Alexopoulos, A.3
Taiafaki, X.4
Rapti, A.5
Veslemes, M.6
Palamidas, P.7
Vlachonikolis, I.8
-
25
-
-
0000564949
-
Prospective randomized study of four third generation chemotherapy regimens in patients with advanced non-small cell lung cancer: A Minnie Pearl Cancer Research Network Trial
-
Thompson D, Hainsworth J, Burris III H, Erland J, Barton J Jr, Brown C, Houston G, Butts J, Scullin D Jr, Greco F: Prospective randomized study of four third generation chemotherapy regimens in patients with advanced non-small cell lung cancer: A Minnie Pearl Cancer Research Network Trial. Proc Am Soc Clin Oncol 2001;20:314a.
-
(2001)
Proc Am Soc Clin Oncol
, vol.20
-
-
Thompson, D.1
Hainsworth, J.2
Burris H. III3
Erland, J.4
Barton J., Jr.5
Brown, C.6
Houston, G.7
Butts, J.8
Scullin D., Jr.9
Greco, F.10
-
26
-
-
0030836373
-
Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology
-
Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16,1997 by the American Society of Clinical Oncology. J Clin Oncol 1997;15:2996-3018.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2996-3018
-
-
-
27
-
-
17344384668
-
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
-
Sandler AB, Nemunaitis J, Denham C, von Pawel J, Cormier Y, Gatzemeier U, Mattson K, Manegold Ch, Palmer MC, Gregor A, Nguyen B, Niyikiza C, Einhorn LH: Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2000;18:122-130.
-
(2000)
J Clin Oncol
, vol.18
, pp. 122-130
-
-
Sandler, A.B.1
Nemunaitis, J.2
Denham, C.3
Von Pawel, J.4
Cormier, Y.5
Gatzemeier, U.6
Mattson, K.7
Manegold, Ch.8
Palmer, M.C.9
Gregor, A.10
Nguyen, B.11
Niyikiza, C.12
Einhorn, L.H.13
-
28
-
-
0033950286
-
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group Trial
-
Bonomi P, Kim KM, Fairclough D, Cella D, Kugler J, Rowinsky E, Jiroutek M, Johnson D: Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group Trial. J Clin Oncol 2000;18:623-631.
-
(2000)
J Clin Oncol
, vol.18
, pp. 623-631
-
-
Bonomi, P.1
Kim, K.M.2
Fairclough, D.3
Cella, D.4
Kugler, J.5
Rowinsky, E.6
Jiroutek, M.7
Johnson, D.8
-
29
-
-
0028154069
-
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
-
Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Liar es P, Chomy P, Cigolari S, Gottfried M, Ruffie P, Panizo A, Gaspard MH, Ravaioli A, Besenval M, Besson F, Martinez A, Berthaud P, Tursz T: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 1994;12:360-367.
-
(1994)
J Clin Oncol
, vol.12
, pp. 360-367
-
-
Le Chevalier, T.1
Brisgand, D.2
Douillard, J.Y.3
Pujol, J.L.4
Alberola, V.5
Monnier, A.6
Riviere, A.7
Liar Es, P.8
Chomy, P.9
Cigolari, S.10
Gottfried, M.11
Ruffie, P.12
Panizo, A.13
Gaspard, M.H.14
Ravaioli, A.15
Besenval, M.16
Besson, F.17
Martinez, A.18
Berthaud, P.19
Tursz, T.20
more..
-
30
-
-
0032701095
-
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
-
Crino L, Scagliotti GV, Ricci S, De Marinis F, Rinaldi M, Gridelli C, Ceribelli A, Bianco R, Marangolo M, Costanzo FD, Sassi M, Barni S, Ravaioli A, Adomo V, Portalone L, Cruciani G, Masotti A, Ferrara G, Gozzelino F, Tonata M: Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol 1999;17:3522-3530.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3522-3530
-
-
Crino, L.1
Scagliotti, G.V.2
Ricci, S.3
De Marinis, F.4
Rinaldi, M.5
Gridelli, C.6
Ceribelli, A.7
Bianco, R.8
Marangolo, M.9
Costanzo, F.D.10
Sassi, M.11
Barni, S.12
Ravaioli, A.13
Adomo, V.14
Portalone, L.15
Cruciani, G.16
Masotti, A.17
Ferrara, G.18
Gozzelino, F.19
Tonata, M.20
more..
-
31
-
-
0000437978
-
Randomized trial comparing cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) versus CPT-11 alone in advanced non-small cell lung cancer (NSCLC)
-
Masuda N, Fukuoka M, Negoro S, Takada Y, Sugiura T, Ohashi Y, Ariyoshi Y, Niitani H: Randomized trial comparing cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) versus CPT-11 alone in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1999;18:459a.
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Masuda, N.1
Fukuoka, M.2
Negoro, S.3
Takada, Y.4
Sugiura, T.5
Ohashi, Y.6
Ariyoshi, Y.7
Niitani, H.8
-
32
-
-
0000829637
-
Preliminary results of a randomized phase III trial of docetaxel (D) and cisplatin (P) versus vindesine (V) and P in stage IV non small cell lung cancer (NSCLC)
-
Kunitoh H, Watanabe K, Ohashi Y, Niitani H: Preliminary results of a randomized phase III trial of docetaxel (D) and cisplatin (P) versus vindesine (V) and P in stage IV non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2001;20:323a.
-
(2001)
Proc Am Soc Clin Oncol
, vol.20
-
-
Kunitoh, H.1
Watanabe, K.2
Ohashi, Y.3
Niitani, H.4
-
33
-
-
17344384670
-
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study
-
Crino L, Scagliotti G, Marangolo M, Figoli F, Clerici M, De Marinis F, Salvati F, Cruciani G, Dogliotti L, Pucci F, Paccagnella A, Adamo V, Altavilla G, Incoronato P, Trippetti M, Mosconi AM, Santucci A, Sorbolini S, Oliva C, Tonato M: Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study. J Clin Oncol 1997;15:297-303.
-
(1997)
J Clin Oncol
, vol.15
, pp. 297-303
-
-
Crino, L.1
Scagliotti, G.2
Marangolo, M.3
Figoli, F.4
Clerici, M.5
De Marinis, F.6
Salvati, F.7
Cruciani, G.8
Dogliotti, L.9
Pucci, F.10
Paccagnella, A.11
Adamo, V.12
Altavilla, G.13
Incoronato, P.14
Trippetti, M.15
Mosconi, A.M.16
Santucci, A.17
Sorbolini, S.18
Oliva, C.19
Tonato, M.20
more..
-
34
-
-
0033967260
-
Phase I/II study of gemcitabin plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer
-
Lorusso V, Carpagnano F, Frasci G, Panza N, Di Rienzo G, Cisternino ML, Napoli G, Orlando S, Cinieri S, Brunetti C, Palazzo S, De Lena M: Phase I/II study of gemcitabin plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer. J Clin Oncol 2000;18:405-411.
-
(2000)
J Clin Oncol
, vol.18
, pp. 405-411
-
-
Lorusso, V.1
Carpagnano, F.2
Frasci, G.3
Panza, N.4
Di Rienzo, G.5
Cisternino, M.L.6
Napoli, G.7
Orlando, S.8
Cinieri, S.9
Brunetti, C.10
Palazzo, S.11
De Lena, M.12
-
35
-
-
0035880703
-
Flexible chemotherapy regimen with gemicitabin and vinorelbine for metastatic nonsmall cell lung carcinoma: A phase II multicenter trial
-
Hirsh V, Langleben A, Ayoub J, Cormier Y, Pintos J, Iglesias JL: Flexible chemotherapy regimen with gemicitabin and vinorelbine for metastatic nonsmall cell lung carcinoma: A phase II multicenter trial. Cancer 2001;92:830-835.
-
(2001)
Cancer
, vol.92
, pp. 830-835
-
-
Hirsh, V.1
Langleben, A.2
Ayoub, J.3
Cormier, Y.4
Pintos, J.5
Iglesias, J.L.6
-
36
-
-
0034853964
-
Gemcitabine plus vinorelbine in stage IIIb or IV non-small cell lung cancer (NSCLC): A multicentre phase II clinical trial
-
Palmeri S, Leonardi V, Gebbia V, De Bella MT, Ferrau F, Faillu G, Spatafora M, Valenza R, Di Vita G, Vitello S, Carroccio R, Sciortino G, Vaglica M, Accurso V, Agostara B, Licata G: Gemcitabine plus vinorelbine in stage IIIb or IV non-small cell lung cancer (NSCLC): A multicentre phase II clinical trial. Lung Cancer 2001;34:115-123.
-
(2001)
Lung Cancer
, vol.34
, pp. 115-123
-
-
Palmeri, S.1
Leonardi, V.2
Gebbia, V.3
De Bella, M.T.4
Ferrau, F.5
Faillu, G.6
Spatafora, M.7
Valenza, R.8
Di Vita, G.9
Vitello, S.10
Carroccio, R.11
Sciortino, G.12
Vaglica, M.13
Accurso, V.14
Agostara, B.15
Licata, G.16
-
37
-
-
0034962362
-
Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer
-
Baron F, Cueva J, Grana B, Curiel T, Leon L, Vazquez F, Candamio S, Lopez R: Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer. Eur J Cancer 2001;37:1381-1384.
-
(2001)
Eur J Cancer
, vol.37
, pp. 1381-1384
-
-
Baron, F.1
Cueva, J.2
Grana, B.3
Curiel, T.4
Leon, L.5
Vazquez, F.6
Candamio, S.7
Lopez, R.8
-
38
-
-
0035097252
-
Gemcitabine and vinorelbine as first-line chemotherapy for advance non-small cell lung cancer: A phase II trial
-
Laack E, Mende T, Benk J, Chemaissani A, Scholtze J, Lorenz C, Niestroy A, Dalhoff K, Muller T, Walter T, Durk H, Edler L, Hossfeld DK: Gemcitabine and vinorelbine as first-line chemotherapy for advance non-small cell lung cancer: A phase II trial. Eur J Cancer 2001;37:583-590.
-
(2001)
Eur J Cancer
, vol.37
, pp. 583-590
-
-
Laack, E.1
Mende, T.2
Benk, J.3
Chemaissani, A.4
Scholtze, J.5
Lorenz, C.6
Niestroy, A.7
Dalhoff, K.8
Muller, T.9
Walter, T.10
Durk, H.11
Edler, L.12
Hossfeld, D.K.13
-
39
-
-
0033014303
-
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II study
-
Georgoulias V, Kouroussis C, Androulakis N, Kakolyris S, Dimopoulos MA, Papadakis E, Bouros D, Apostolopoulou F, Papadimitriou C, Agelidou A, Hatzakis K, Kalbakis K, Kotsakis A, Vardakis N, Vlachonicolis J: Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II study. J Clin Oncol 1999;17:914-920.
-
(1999)
J Clin Oncol
, vol.17
, pp. 914-920
-
-
Georgoulias, V.1
Kouroussis, C.2
Androulakis, N.3
Kakolyris, S.4
Dimopoulos, M.A.5
Papadakis, E.6
Bouros, D.7
Apostolopoulou, F.8
Papadimitriou, C.9
Agelidou, A.10
Hatzakis, K.11
Kalbakis, K.12
Kotsakis, A.13
Vardakis, N.14
Vlachonicolis, J.15
-
40
-
-
0035865303
-
Phase II trial of paclitaxel and gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer
-
Isla D, Rosell R, Sanchez JJ, Carrato A, Felip E, Camps C, Artal A, Gonzalez-Larriba JL, Azagra P, Alberola V, Martin C, Massuti B: Phase II trial of paclitaxel and gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2001;19:1071-1077.
-
(2001)
J Clin Oncol
, vol.19
, pp. 1071-1077
-
-
Isla, D.1
Rosell, R.2
Sanchez, J.J.3
Carrato, A.4
Felip, E.5
Camps, C.6
Artal, A.7
Gonzalez-Larriba, J.L.8
Azagra, P.9
Alberola, V.10
Martin, C.11
Massuti, B.12
-
41
-
-
0029964170
-
Ifosfamide plus paclitaxel in advanced non-small cell lung cancer: A phase I study
-
Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE: Ifosfamide plus paclitaxel in advanced non-small cell lung cancer: A phase I study. Ann Oncol 1996;7:314-316.
-
(1996)
Ann Oncol
, vol.7
, pp. 314-316
-
-
Hoffman, P.C.1
Masters, G.A.2
Drinkard, L.C.3
Krauss, S.A.4
Samuels, B.L.5
Golomb, H.M.6
Vokes, E.E.7
-
42
-
-
0031956320
-
Ifosfamide and paclitaxel combination fot the treatment of advanced non-small cell lung cancer
-
Shepherd FA, Eisenhauer E: Ifosfamide and paclitaxel combination fot the treatment of advanced non-small cell lung cancer. Semin Oncol 1998;25(suppl 2):2-7.
-
(1998)
Semin Oncol
, vol.25
, Issue.SUPPL. 2
, pp. 2-7
-
-
Shepherd, F.A.1
Eisenhauer, E.2
-
43
-
-
0032744521
-
Ifosfamide in non-small-cell lung cancer
-
Rosell R, Martin C, Balana C: Ifosfamide in non-small-cell lung cancer. Ann Oncol 1999;10(suppl 5):25-28.
-
(1999)
Ann Oncol
, vol.10
, Issue.SUPPL. 5
, pp. 25-28
-
-
Rosell, R.1
Martin, C.2
Balana, C.3
-
44
-
-
0031049131
-
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer
-
Masters GA, Hoffman PC, Hsieh A, Drinkard LC, Mick R, Samuels BL, Guaspari A, Golomb HM, Vokes EE: Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer. J Clin Oncol 1997;15:884-892.
-
(1997)
J Clin Oncol
, vol.15
, pp. 884-892
-
-
Masters, G.A.1
Hoffman, P.C.2
Hsieh, A.3
Drinkard, L.C.4
Mick, R.5
Samuels, B.L.6
Guaspari, A.7
Golomb, H.M.8
Vokes, E.E.9
-
45
-
-
0033993472
-
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALBG 9532
-
Perry MC, Ihde DC, Herndon II JE, Grossbard ML, Grethein SJ, Atkins JN, Vokes EE, Green MR: Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALBG 9532. Lung Cancer 2000;28:63-68.
-
(2000)
Lung Cancer
, vol.28
, pp. 63-68
-
-
Perry, M.C.1
Ihde, D.C.2
Herndon J.E. II3
Grossbard, M.L.4
Grethein, S.J.5
Atkins, J.N.6
Vokes, E.E.7
Green, M.R.8
|